Insulin resistance in brain and possible therapeutic approaches

Current Vascular Pharmacology

Volumn 12, Issue 4, 2014, Pages 553-564

  Cetinkalp, Sevki ^a   Simsir, Ilgin Y ^a   Ertek, Sibel ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Turkish Ministry of Health anliurfa Education and Research Hospital   (Turkey)

Author keywords

Brain; Hypothalamus; Insulin resistance; Leptin

Indexed keywords

INSULIN; METFORMIN; PLACEBO; GLUCOSE; INSULIN RECEPTOR; LEPTIN;

ARTICLE; FOOD INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPOINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; COGNITION DISORDERS; DEMENTIA; LIVER; METABOLISM; PANCREAS ISLET;

ANIMALS; BRAIN; COGNITION DISORDERS; DEMENTIA; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LEPTIN; LIVER; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 84904758220     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161112999140206130426     Document Type: Article

References (122)

1. Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26: 98-106.
2. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 14: 741-51.
3. Ahima RS, Osei SY. Adipokines in obesity. Front Horm Res 2008; 36: 182-97.
4. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008; 34: 2-11.
5. Hopkins DF, Williams G. Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity. Diabet Med 1997; 14: 1044-1050.
6. Lund-Andersen H. Transport of glucose from blood to brain. Physiol Rev 1979; 59: 305-52.
7. Ketterer C, Tschritter O, Preissl H, Heni M, Häring HU, Fritsche A. Insulin sensitivity of the human brain. Diabetes Res Clin Pract 2011; 93 (Suppl 1): S47-51.
8. Brüning JS, Gautam D, Burks DJ, et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 289: 2122-2125.
9. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8: 1376-82.
10. Pocai A, Lam TK, Gutierrez-Juarez R, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005; 434: 1026-31.
11. Ramnanan CJ, Saraswathi V, Smith MS, et al. Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs. J Clin Invest 2011; 121: 3713-23.
12. D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 1996; 13: 227-55.
13. Farooqui AA, Farooqui T, Panza F, Frisardi V. Metabolic syndrome as a risk factor for neurological disorders. Cell Mol Life Sci 2012; 69: 741-62.
14. Chang L, Chiang SH, Saltiel AR. Insulin signaling and the regulation of glucose transport. Mol Med 2004; 10: 65-71.
15. McTernan PG, Harte AL, Anderson LA, Green A, Smith SA, Holder JC, Barnett AH, Eggo MC, Kumar S. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes 2002; 51: 1493-8.
16. Scherer T, O'Hare J, Diggs-Andrews K, et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 2011; 13: 183-94.
17. Sonksen PH. Insulin, growth hormone and sport. J Endocrinol 2001; 170: 13-25.
18. Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978; 272: 827-9.
19. Woods SC, Lotter EC, McKay LD, Porte D Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979; 282: 503-5.
20. Schwartz M, Sipols AJ, Marks JL, et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 1992; 130: 3608-16.
21. Masaki T, Chiba S, Noguchi H, et al. Obesity in insulin receptor substrate-2-deficient mice: disrupted control of arcuate nucleus neuropeptides. Obes Res 2004; 12: 878-85.
22. Lin X, Taguchi A, Park S, et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 2004; 114: 908-16.
23. Laron Z. Insulin and the brain. Arch Physiol Biochem 2009; 115: 112-6.
24. Pardridge WM, Eisenberg J, Yang J. Human blood brain barrier insulin receptor. J Neurochem 1985; 44: 1771-8.
25. Banks WA. The source of cerebral insulin. Eur J Pharmacol 2004; 490: 5-12.
26. Clarke DW, Mudd L, Boyd FT, Fields M, Raizada MK. Insulin is released from rat brain neuronal cells in culture. J Neurochem 1986; 47: 831-6.
27. Van Houten M, Posner BI, Kopriwa BM, Brawer JR. Insulin binding sites in the rat brain: in vivolocalisation to the circumventricular organs by quantitative autoradiography. Endocrinology 1979; 105: 666-73.
28. Wallum BJ, Porte D Jr, Figlewicz DP, et al. Cerebrospinal fluid insulin levels increase during intravenous insulin infusion in man. J Clin Endocrinol Metab 1987; 64: 190-4.
29. Banks WA, Jaspan JB, Huang W, Kastin AJ. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 1997; 18: 1423-9.
30. Banks WA, Jaspan JB, Kastin AJ. Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides 1997; 18: 1577-84.
31. Zhu SQ, Kum W, Ho SK, Young JD, Cockram SS. Structure fonction relationships of insulin receptor interactions in cultered Mouse astrocytes. Brain Res 1990; 529: 329-32.
32. Marks JL, Porte D Jr, Stahl WL, Baskin DG. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 1999; 127: 3234-6.
33. Carayannopoulos MO, Chi MM, Cui Y, et al. GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. Proc Natl Acad Sci USA 2000; 97: 7313-8.
34. Pellerin L, Bouzier-Sore AK, Aubert A, Serres S, et al. Activity dependent regulation of energy metabolism by astrocytes: an update. Glia 2007; 55: 1251-62.
35. Werther GA, Hogg A, Oldfield BJ, et al. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitroautoradiography and computerized densitometry. Endocrinology 1987; 121: 1562-70.
36. Abbott MA, Wells DG, Fallon JR. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci 1999; 19: 7300-8.
37. Suzuki R, Lee K, Jing E, et al. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab 2010; 12: 567-79.
38. Kopf SR, Baratti CM. Effects of posttraining administration of insulin on retention of a habituation response in mice: participation of a central cholinergic mechanism. Neurobiol Learn Mem 1999; 71: 50-61.
39. Figlewicz DP, Szot P, Israel PA, Payne C, Dorsa DM. Insulin reduces norepineph-rine transporter mRNA in vivoin rat locus coeruleus. Brain Res 1993; 602: 161-4.
40. Tschritter O, Preissl H, Hennige AM, et al. The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci USA 2006; 103: 12103-8.
41. Hasselbalch SG, Knudsen GM, Videbaek C, et al. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 1999; 48: 1915-21.
42. Bingham EM, Hopkins D, Smith D, et al. The role of insulin in human brain glucose metabolism: An 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002; 51: 3384-90.
43. Heni M, Hennige AM, Peter A, et al. Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS ONE 2011; 6(6), e21594.
44. Huising MO, van der Meulen T, Vaughan JM, et al. CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proc Natl Acad Sci USA 2010; 107: 912-7.
45. Huising MO, Pilbrow AP, Matsumoto M, et al. Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2αin MIN6 insulinoma cells and rodent islets. Endocrinology 2011; 152: 138-50.
46. Chen A, Perrin M, Brar B, et al. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Mol Endocrinol 2005; 19: 441-58.
47. Makino S, Nishiyama M, Asaba K, Gold PW, Hashimoto K. Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. Am J Physiol 1998; 275(4 Pt 2): R1138-45.
48. Niijima A. Blood glucose levels modulate efferent activity in the vagal supply to the rat liver. J Physiol 1985; 364: 105-12.
49. Pistell PJ, Morrison CD, Gupta S, et al. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 2010; 219: 25-32.
50. Shimazu T, Fukuda A, Ban T. Reciprocal influences of the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content. Nature 1966; 210: 1178-9.
51. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007; 4: 147-52.
52. Craft S. Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord 2006; 20: 298-301.
53. Winocur G, Greenwood CE, Piroli GG, et al. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci 2005; 119: 1389-95.
54. Winocur G, Greenwood CE. Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiol Aging 2005; 1(6 Suppl): 46-9.
55. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006; 45: 42-72.
56. Katsel P, Li C, Haroutunian V. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res 2007; 32: 845-56.
57. Lyn-Cook Jr LE, Lawton M, Tong M, et al. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis, J Alzheimers Dis 2009; 16(4): 715-29.
58. Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH. Daily rhythm in human urinary melatonin. Science 1975; 187(4172): 169-71.
59. Lynch HJ. Diurnal oscillations in pineal melatonin content. Life Sci I 1971; 10(14): 791-5.
60. Moore RY, Klein DC. Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase activity. Brain Res 1974; 71(1): 17-33.
61. Byberg S, Hansen AL, Christensen DL, et al. Sleep duration and sleep quality are associated differently with alterations of glucose homeostasis. Diabet Med 2012 May 15. [Epub ahead of print].
62. Nogueira TC, Lellis-Santos C, Jesus DS, et al. Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response. Endocrinology 2011; 152(4): 1253-63.
63. Williamson R, McNeilly A, Sutherland C. Insulin resistance in the brain: An old-age or new-age problem? Biochem Pharmacol 2012 May 16. [Epub ahead of print].
64. Sanchez-Alavez M, Osborn O, Tabarean IV, et al. Insulin-like growth factor 1-mediated hyperthermia involves anterior hypothalamic insulin receptors. J Biol Chem 2011; 286: 14983-90.
65. Scherer T, O'Hare J, Diggs-Andrews K, et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 2011; 13: 183-94.
66. Cai D, Liu T. Inflammatory cause of metabolic syndrome via brain stress and NFαB. Aging 2012; 4(2): 98-115.
67. Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for selfαeating. Cell Death Differ 2005; 12 (Suppl 2): 1542α52.
68. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27α42.
69. Martinez-Vicente M, Cuervo AM. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 2007; 6: 352α61.
70. Zhang X, Dong F, Ren J, Driscoll MJ, Culver B. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol 2005; 191: 318-25.
71. De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fatrich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005; 146: 4192-9.
72. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. Hypothalamic IKKα/NF-αand ER stress link overnutrition to energy imbalance and obesity. Cell 2008; 135: 61-73.
73. Kim F, Pham M, Luttrell I, et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 2007; 100: 1589-96.
74. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 2008; 16: 1248-55.
75. Munzberg H, Flier JS, Bjørbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004; 145: 4880-9.
76. Thaler JP, Schwartz MW. Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 2010; 151(9): 4109-15.
77. Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, Kahn BB. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 2008; 283: 14230-41.
78. White CL, Whittington A, Barnes MJ, Wang Z, Bray GA, Morrison CD. HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and-independent mechanisms. Am J Physiol Endocrinol Metab 2009; 296: E291-9.
79. Bence KK, Delibegovic M, Xue B, et al. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 2006; 12: 917-24.
80. Banno R, Zimmer D, De Jonghe BC, et al. PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J Clin Invest 2010; 120: 720-34.
81. Himes RW, Smith CW. Tlr2 is critical for dietαinduced metabolic syndrome in a murine model. FASEB J 2010; 24: 731α9.
82. Hauwel M, Furon E, Canova C, Griffiths M, Neal J, Gasque P. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res Rev 2005; 48: 220α33.
83. Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009; 29: 359α70.
84. Bomfim TR, Forny-Germano L, Sathler LB, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aαoligomers. J Clin Invest 2012; 122(4): 1339-53.
85. Talbot K, Wang HY, Kazi H, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012; 122(4): 1316-38.
86. Stolk RP, Breteler MM, Ott A, et al. The Rotterdam study. Insulin and cognitive function in an elderly population. Diabetes Care 1997; 20(5): 792-5.
87. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18(4): 351-9.
88. Casedesus G, Puig ER, Webber KM, et al. Targeting gonadotropins: an alternative option for Alzheimer disease treatment. J Biomed Biotechnol 2006; 3: 39508.
89. Erol A. Unraveling the molecular mechanisms behind the metabolic basis of sporadic Alzheimer's disease. J Alzheimers Dis 2009; 17(2): 267-76.
90. De la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2008; 2(6): 1101-13.
91. Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 2008; 5(3-4): 118-21.
92. Wang XP, Ding HL. Alzheimer's disease: epidemiology, genetics, and beyond. Neurosci Bull 2008; 24(2): 105-9.
93. De la Monte SM, Wands JR. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 2005; 7(1): 45-61.
94. De la Monte SM. Insulin resistance and Alzheimer's disease. BMB Rep 2009; 42(8): 475-81.
95. Lee EB. Obesity, leptin, and Alzheimer's disease. Ann NY Acad Sci 2011; 1243: 15-29.
96. Labrousse VF, Nadjar A, Joffre C, et al. Short-term long chain omega 3 diet protects from neuroinflammatory processes and memory impairment in aged mice. PLoS ONE 2012; 7(5): e36861.
97. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease, Neuron 2009; 63(3): 287-303.
98. Solfrizzi V, Panza F, Frisardi V, et al. Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev Neurother 2011; 11(5): 677-708.
99. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006; 58: 912-21.
100. Ertek S, Cicero A. Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions. Arch Med Sci 2012; 8: 794-804.
101. Coelho FG, Andrade LP, Pedroso RV, et al. Multimodal exercise intervention improves frontal cognitive functions and gait in Alzheimer's disease: A controlled trial. Geriatr Gerontol Int 2012 Jun 11. [Epub ahead of print].
102. Cicero AF, Tartagni E, Ertek S. Metformin and its clinical use: new insights for an old drug in clinical practice. Arch Med Sci 2012; 8: 907-17.
103. Kickstein E, Krauss S, Thornhill P, et al. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc Natl Acad Sci USA 2010; 107: 21830-5.
104. Chen Y, Zhou K, Wang R, et al. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Proc Natl Acad Sci USA 2009; 106: 3907-12.
105. Hsu CC, Wahlqvist ML, Lee MS, Tsai HN. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 2011; 24: 485-93.
106. Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012; 69(1): 29-38.
107. Pipatpiboon N, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. PPARagonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 2012; 153(1): 329-38.
108. Watson GS, Cholerton BA, Reger MA, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 2005; 13: 950-8.
109. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci 2000; 20: 558-67.
110. Delerive P, Fruchart JC, Staels B. Peroxisome proliferatoractivated receptors in inflammation control. J Endocrinol 2001; 169: 453-9.
111. McClean PL, Parthsarathy V, Faivre E, Holscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 2011; 31: 6587-94.
112. Bomfim TR, Forny-Germano L, Sathler LB, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers. J Clin Invest 2012; 122: 1339-53.
113. Agrawal R, Gomez-Pinilla F. Metabolic syndrome in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J Physiol 2012 Apr 2 [Epub ahead of print].
114. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-72.
115. Posey KA, Clegg DJ, Printz RL, et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 2009; 296: E1003-12.
116. Boaz M, Lisy L, Zandman-Goddard G, Wainstein J. The effect of anti-inflammatory (aspirin and/or statin) therapy on body weight in type 2 diabetic individuals: EAT, a retrospective study. Diabet Med 2009; 26: 708-13.
117. Ozcan L, Ergin AS, Lu A, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 2009; 9: 35-51.
118. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-91.
119. Hedbacker K, Birsoy K, Wysocki RW, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 2010; 11: 11-22.
120. Koch C, Augustine RA, Steger J, et al. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J Neurosci 2010; 30(48): 16180-7.
121. Kleinridders A, Schenten D, Konner AC, et al. MyD88 signaling in the CNS is required for development of fatty acid induced leptin resistance and dietαinduced obesity. Cell Metab 2009; 10: 249α59.
122. Ropelle ER, Flores MB, Cintra DE, et al. IL-6 and IL-10 antiinflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKK beta and ER stress inhibition. PLoS Biol 2010; 8(8). pii: e1000465.